Stockreport

Quanterix’ Ultra-Sensitive Simoa Technology Demonstrates Promise for COVID-19 Acute Care, Immune Response Monitoring and Treatment

Quanterix Corporation  (QTRX) 
US:NASDAQ Investor Relations: ir.quanterix.com/investor-relations
PDF Powering Precision Health (PPH) Think Tank convenes 500+ attendees, including top physicians from the pandemic frontlines, to discuss Simoa-enabled biomarker strategies [Read more]